Guglielmi, Valeria
Visser, Jeldican
Arnold, Marcel
Sarikaya, Hakan
van den Berg, René
Nederkoorn, Paul J.
Leys, Didier
Calvet, David
Kloss, Manja
Pezzini, Alessandro
Tatlisumak, Turgut
Schilling, Sabrina
Debette, Stéphanie
Coutinho, Jonathan M. http://orcid.org/0000-0002-8284-982X
Article History
Received: 21 December 2018
Revised: 1 March 2019
Accepted: 5 March 2019
First Online: 23 March 2019
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. Dr. Nederkoorn received a research grant from The Netherlands Organisation for Scientific Research. Dr. Sarikaya has received research grants from Bangerter Foundation, Hermann Klaus Foundation, The Swiss Heart Foundation, and The Swiss National Science Foundation and has received speaker honoraria from Biogen and Mepha; he has served on scientific advisory boards for Bayer, Boehringer-Ingelheim, BMS/Pfizer, Biogen, Merck and Novartis. Prof. Dr. Arnold has received speaker honoraria from Bayer, Boehringer Ingelheim, and Covidien, and scientific advisory board honoraria from Amgen, Bayer, Boehringer Ingelheim, BMS, Pfizer, Covidien, Daichy Sankyo and Nestlé Health Science. Dr. van den Berg has a consultancy agreement with Cerenovus neurovascular. Prof. Dr. Tatlisumak served on advisory boards for Bayer, Boehringer Ingelheim, BrainsGate, and Lumosa Pharma; has/has had research contracts with Bayer, Boehringer Ingelheim, Portola Pharm, and Pfizer. Dr. Coutinho received scientific advisory board honoraria from Boehringer Ingelheim. All other authors declare no disclosures.
: All studies in this review have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.